Rosacea on the nose and rhinophyma: an evidence-informed overview

The nose is one of the most commonly affected zones in rosacea — and one of the most distressing. Persistent redness, visible vessels, and bumpy texture are common, and a smaller subset of people develop progressive thickening called rhinophyma. The Canadian Clinical Practice Guidelines for Rosacea, co-authored by Dr. Jason Rivers, recognise nasal involvement across several rosacea phenotypes and emphasise early evaluation when thickening is suspected — because outcomes are better with earlier intervention (Asai et al. 2016, J Cutan Med Surg, PMID 27207355).

This guide explains what nasal rosacea typically looks like, separates it from conditions that can mimic it, and walks through what evidence-based treatment options actually look like.

How rosacea presents on the nose

The nose participates in nearly every rosacea phenotype to some degree, but the pattern depends on which features predominate.

Persistent redness on the nose and central face. Often described as the classic “rosy” appearance — a steady pink or red across the bridge of the nose and the inner cheeks, persisting between flares rather than only during them. The 2017 update to the National Rosacea Society’s standard classification specifically lists persistent centrofacial erythema as a diagnostic feature for rosacea (Gallo et al. 2018, J Am Acad Dermatol, PMID 29089180).

Visible small blood vessels (telangiectasia). Threadlike red or purple lines, particularly along the alae and the bridge. These don’t blanch with pressure the way a fresh flush does, and they don’t disappear with skincare alone — they reflect dilated, structurally remodelled vessels.

Papules and pustules on the nose and adjacent zones. Inflammatory bumps, sometimes confused with adult acne. Unlike acne, rosacea papules don’t typically have comedones (blackheads or whiteheads), and the surrounding skin is more diffusely red.

Sensitivity, stinging, or burning. A frequent complaint with no visible cause — products that other people tolerate sting on the nose, or hot drinks set off a sensation of warmth that lasts longer than the drink itself.

Texture changes (thickening, bumpiness, enlarged pores). This is where the pattern moves from inflammatory rosacea toward the phymatous spectrum. The skin starts to feel firmer, the pores look enlarged, and over years the nose may become bulbous in a phenomenon called rhinophyma.

What rhinophyma actually is

Rhinophyma is the name for progressive enlargement and disfigurement of the nose due to thickening of the skin and the underlying sebaceous glands. The 2017 ROSCO consensus on rosacea diagnosis classifies “phymatous changes” as a major rosacea phenotype, including rhinophyma (nose), gnathophyma (chin), metophyma (forehead), otophyma (ear), and blepharophyma (eyelid) — though the nose is by far the most commonly affected (Tan et al. 2017, Br J Dermatol, PMID 27718519).

Histologically, rhinophyma involves sebaceous gland hyperplasia, fibrosis, and chronic inflammation. The clinical course is typically slow — years, not weeks — and the changes are not painful, but they can be psychologically distressing and, in advanced cases, can affect breathing or vision (when adjacent zones are involved).

A few things rhinophyma is not:

• It is not caused by alcohol. The popular cultural association (“drinker’s nose”) is a stigma without basis. Alcohol can flush rosacea-prone vessels in the short term and may contribute to inflammation, but it does not cause rhinophyma in someone who drinks moderately.
• It is not contagious.
• It is not necessarily preceded by years of severe inflammatory rosacea. Some patients develop phymatous changes with relatively mild prior rosacea history; others have severe inflammatory rosacea without ever progressing to rhinophyma.

The condition disproportionately affects men, particularly those of fair skin and Northern European ancestry, with onset typically in middle age and beyond. Women can develop rhinophyma but do so much less commonly.

What can mimic rosacea on the nose

A few conditions can present similarly enough that a clinical evaluation is worthwhile rather than self-diagnosis:

• Seborrheic dermatitis. Flaky, slightly yellow scale on the alar grooves alongside redness. Can coexist with rosacea.
• Perioral dermatitis. Small papules around the nose and mouth, often after topical steroid use or over-cleansing.
• Lupus erythematosus. A “butterfly rash” across cheeks and nose can resemble rosacea but has different clinical and serological features.
• Sarcoidosis. Granulomatous nasal involvement is rare but can present with thickening.
• Squamous cell carcinoma or basal cell carcinoma. A persistent, non-healing scaly or ulcerated lesion on the nose — particularly in fair-skinned older adults with a history of sun exposure — should always be assessed.

If the appearance is changing rapidly, ulcerating, bleeding, or asymmetrical, that’s a reason to see a dermatologist promptly rather than assume rosacea (van Zuuren et al. 2019, Br J Dermatol, PMID 30585305).

What helps day-to-day

The same calm baseline that supports the rest of the face also helps the nose:

A gentle, fragrance-free cleanser; a barrier-supportive moisturiser; daily broad-spectrum mineral sunscreen. For the nose specifically — which is often the most sun-exposed zone of the face — a tinted mineral SPF that includes iron oxides for visible-light protection is particularly useful. See mineral sunscreen for rosacea for selection criteria.

Trigger management — heat, sun, alcohol, hot drinks, and very spicy food — is often most important here because the nasal vessels seem most reactive. The 2017 update to NRS criteria specifically highlights repeated flushing as a likely contributor to long-term vascular and tissue changes (Gallo et al. 2018, PMID 29089180).

Avoid harsh exfoliation, scrubs, and strong actives on the nose. The temptation when texture changes start is to over-treat with acids or cleansing brushes; this typically worsens both inflammation and tissue changes.

Treatment options for inflammatory rosacea on the nose

For inflammatory papules and pustules:

• Topical ivermectin 1% has high-quality randomised evidence for papulopustular rosacea, including involvement of the central face and nose (Stein et al. 2014, J Drugs Dermatol, PMID 24595578).
• Topical metronidazole has long-standing evidence and is widely used.
• Topical azelaic acid 15% gel or 20% cream is well evidenced and may suit patients who prefer a non-antibiotic option.
• Subantibiotic-dose oral doxycycline (40 mg modified release) has phase III evidence for inflammatory rosacea and is dosed below the antibacterial threshold to minimise resistance concerns (Del Rosso et al. 2007, J Am Acad Dermatol, PMID 17367893).

For persistent erythema and visible vessels:

• Topical brimonidine (alpha-2 agonist) and oxymetazoline (alpha-1A agonist) constrict surface vessels for several hours after application and are used for transient redness reduction (Fowler et al. 2013, J Drugs Dermatol, PMID 23839181; Kircik et al. 2018, J Drugs Dermatol, PMID 29320594).
• Pulsed dye laser (PDL) and intense pulsed light (IPL) target the dilated vessels themselves and are the standard treatments for telangiectasia and persistent erythema. Multiple sessions are typical; both are reasonable options with comparable efficacy (PDL vs IPL meta-analysis 2021, J Cosmet Laser Ther, PMID 34291712).

For an overview of all treatment options including how they’re sequenced, see our rosacea treatment pillar.

Treatment options specifically for rhinophyma

When phymatous changes are established, the goals of treatment are to halt progression and to reshape (debulk) tissue that has already thickened.

Slowing progression. Inflammatory control is key. Long-term low-dose oral isotretinoin has a body of evidence in rosacea and may slow phymatous changes in some patients, though it is a specialist medication with significant precautions and is not appropriate for everyone (van Zuuren et al. 2019, PMID 30585305). Conventional topicals are useful for the inflammatory component but don’t reverse established thickening.

Reshaping established rhinophyma. Several procedural options exist:

• Ablative CO2 or erbium:YAG laser resurfacing. The standard contemporary option for moderate rhinophyma. The laser vaporises layers of thickened tissue, allowing the underlying contour to be reshaped. Healing takes 1–3 weeks; results are durable.
• Electrosurgery and radiofrequency. Similar concept — controlled tissue removal — using electrical energy. Often combined with cold steel for finer contouring.
• Surgical excision and dermabrasion. Older techniques, still appropriate for very advanced rhinophyma or in centres without laser access.

These are specialist procedures and are typically performed by a dermatologic surgeon, plastic surgeon, or otolaryngologist with specific experience in rhinophyma. Outcomes are generally good but expectations should be managed: the goal is to restore an approximately normal contour, not to eliminate every blood vessel or pore.

When to see a dermatologist

Not every rosy nose needs a dermatologist on day one. But specific patterns warrant evaluation:

• Texture changes — bumpiness, firmness, enlarged pores — that are progressing month over month rather than fluctuating.
• Persistent redness or visible vessels that don’t respond to gentle skincare and trigger management.
• Inflammatory papules or pustules that don’t settle within a few weeks of consistent gentle care.
• Eye involvement — gritty sensation, dryness, recurrent styes — alongside facial symptoms.
• Any non-healing, ulcerated, bleeding, or asymmetric lesion on the nose, regardless of context.

Earlier evaluation gives more options. Established rhinophyma is treatable, but inflammatory control begun earlier in the course can sometimes prevent or limit it. For an overview of how the various options fit together, see our rosacea treatment pillar.

Frequently asked questions

Does drinking alcohol cause rhinophyma?

No. The cultural stereotype of “drinker’s nose” is stigma, not science. Alcohol can flush rosacea-prone vessels in the short term and may contribute to general inflammation, but it does not cause rhinophyma in someone who drinks moderately. Heavy drinkers with no rosacea-prone genetics rarely develop rhinophyma; lifelong non-drinkers with phymatous-type rosacea sometimes do.

Will my nose definitely thicken if I have rosacea?

No. Most people with rosacea never develop phymatous changes. The phymatous phenotype is a distinct presentation that affects a minority of patients, and it overlaps incompletely with inflammatory rosacea severity.

Can rhinophyma be reversed without surgery?

Established thickening cannot be fully reversed with topicals or oral medication. Inflammatory control may slow progression. For visible reshaping, procedural treatments — ablative laser, electrosurgery, or surgical contouring — are the evidence-based options.

Does laser treatment hurt, and what’s the recovery like?

Vascular laser (PDL/IPL) for redness and vessels is mildly uncomfortable — often described as a snap or a hot pinprick — and recovery is typically a day or two of mild redness or bruising. Ablative resurfacing for rhinophyma is a more substantial procedure with 1–3 weeks of healing under occlusive dressings or ointment.

Is rhinophyma a sign of severe rosacea?

It’s a sign of a particular phymatous phenotype rather than a severity grade. Some patients have severe inflammatory rosacea without phymatous progression; others have mild inflammatory disease with significant phymatous changes. They reflect different aspects of the same condition.

Can sunscreen prevent rhinophyma?

Daily sunscreen is part of foundational rosacea care and is supported by guidelines (Asai et al. 2016, PMID 27207355). UV exposure contributes to vascular and dermal damage, so consistent SPF likely helps overall progression. There’s no clinical trial showing sunscreen specifically prevents rhinophyma, but the rationale and overall benefit are strong.

Should I avoid retinoids if I have nasal rosacea?

Not necessarily. Topical retinoids can be useful for some patients, and oral isotretinoin in low doses is one of the few interventions with evidence for slowing phymatous progression. The right answer depends on phenotype and individual tolerance — coordinate with a dermatologist.

My nose is big but smooth, no bumps — is that rhinophyma?

A naturally larger or wider nose, without skin thickening or bumpy texture, isn’t rhinophyma. Rhinophyma is specifically about progressive skin thickening and sebaceous gland enlargement that distorts contour. Anatomy varies; if the change is recent and progressive, see a clinician.